EULAR 2024, video met Quirine Dumoulin, LUMC Leiden 

June 2024
RA
ACPA
methotrexaat
EULAR 2024
Treat Earlier
Dumoulin
POS0061 – Interception of the development of rheumatoid arthritis by a 1-year course of methotrexate in ACPA-negative arthralgia patients at increased risk for rheumatoid arthritis: 4 year results of the TREAT EARLIER trial Naar de EULAR Download hier de poster
Wilt u meer lezen? Log dan in.

Gerelateerde items

EULAR 2025, video met Sytske Anne Bergstra, LUMC

POS0431 – Drug free remission and the risk of involvement of new joints in early rheumatoid arthriti ...

Lees meer

EULAR 2025, video met Elise van Mulligen, LUMC

POS0582 – Risk-Stratified Cost-Utility Analysis of the TREAT EARLIER Trial: One-Year Methotrexate Tr ...

Lees meer

EULAR 2025, video met Sina Fadaei, UMCU

POS0592 – Effectiveness of Tocilizumab vs Prednisone In Rheumatoid Arthritis Patients with Insuffici ...

Lees meer

EULAR 2025, video met Arjen Stoppelenburg, UMCU en UU

POS0743 – Harnessing Tolerogenic Dendritic Cells for Antigen-Specific Immune Modulation in Rheumatoi ...

Lees meer